Hi friends
Dr. John Pagel discusses the risks and benefits of ABT-199 and TRU-016 in CLL (chronic lymphocytic leukemia) in an interview from ASH 2013 that I just posted on my blog bkoffman.blogspot.com
I am off to ASCO later this week with an absolutely crazy schedule of interviews, lectures and meetings that I want to bring to the CLL community over the ensuing months.
Stay strong.
Brian
Dr. O'Brien on how she treats CLL frontline and Dr. Pagel on new ways to block BTKASH 2016: Dr. Seymour on Combination therapies with venetoclaxMy 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.
Calling all treated with Venetoclax/Venclexa/ABT-199 - and all others interested in supporting Australians to gain non-chemo CLL treatmentPart 2 of ASH Interview with Dr. Sharman, a patient meeting in Seattle and off to iwCLL later tonight
